ES2574902T3 - Formulación alimenticia que comprende glucógeno - Google Patents

Formulación alimenticia que comprende glucógeno Download PDF

Info

Publication number
ES2574902T3
ES2574902T3 ES10739348.0T ES10739348T ES2574902T3 ES 2574902 T3 ES2574902 T3 ES 2574902T3 ES 10739348 T ES10739348 T ES 10739348T ES 2574902 T3 ES2574902 T3 ES 2574902T3
Authority
ES
Spain
Prior art keywords
glycogen
glucose
food formulation
less
released
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10739348.0T
Other languages
English (en)
Inventor
Vincenzo Russo
Elisa Liberati
Giuseppe Biondi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of ES2574902T3 publication Critical patent/ES2574902T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Formulación alimenticia artificial para su utilización en la liberación controlada de glucosa que comprende glucógeno y por lo menos otro componente comestible, caracterizada por que dicho glucógeno presenta un peso molecular entre 2.000.000 y 5.000.000 Daltons, y un porcentaje de enlaces glucosídicos a-1-6 de entre 5% y 15%, con respecto al número total de enlaces, y comprende menos de 1% en peso de azúcares reductores, y en la que dicha liberación controlada de glucosa es tal que (i) aproximadamente 50% de glucosa se libera en no menos de 5 horas y (ii) aproximadamente 80% de glucosa se libera en no menos de 12 horas.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES10739348.0T 2009-08-03 2010-07-29 Formulación alimenticia que comprende glucógeno Active ES2574902T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09425315 2009-08-03
EP09425315 2009-08-03
PCT/EP2010/061002 WO2011015509A1 (en) 2009-08-03 2010-07-29 Food formulation comprising glycogen

Publications (1)

Publication Number Publication Date
ES2574902T3 true ES2574902T3 (es) 2016-06-23

Family

ID=41278792

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10739348.0T Active ES2574902T3 (es) 2009-08-03 2010-07-29 Formulación alimenticia que comprende glucógeno

Country Status (25)

Country Link
US (1) US8889654B2 (es)
EP (1) EP2461701B1 (es)
JP (1) JP5639649B2 (es)
KR (1) KR101752335B1 (es)
CN (1) CN102469817B (es)
AR (1) AR077343A1 (es)
AU (1) AU2010280835B2 (es)
BR (1) BR112012002350B1 (es)
CA (1) CA2760177C (es)
CY (1) CY1117686T1 (es)
DK (1) DK2461701T3 (es)
EA (1) EA028124B1 (es)
ES (1) ES2574902T3 (es)
GE (1) GEP20156287B (es)
HR (1) HRP20160722T1 (es)
HU (1) HUE027721T2 (es)
IL (1) IL217462A (es)
MX (1) MX2012001518A (es)
PL (1) PL2461701T3 (es)
PT (1) PT2461701E (es)
SG (2) SG178069A1 (es)
SI (1) SI2461701T1 (es)
SM (1) SMT201600163B (es)
UA (1) UA106238C2 (es)
WO (1) WO2011015509A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102214865B1 (ko) 2013-04-26 2021-02-15 마이렉서스 바이오테크놀로지스 인코퍼레이티드 파이토글리코겐 나노입자와 이를 제조하는 방법
EP3216455A4 (en) * 2014-11-07 2018-06-20 Nichirei Biosciences Inc. Alcohol metabolism promoter

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8402573D0 (en) 1984-02-01 1984-03-07 Fisons Plc Oral formulation
JPS62178505A (ja) 1986-02-03 1987-08-05 Maruzen Kasei Kk 化粧料
JPS63290809A (ja) 1987-05-25 1988-11-28 Noebia:Kk 口唇用化粧料
JPH0773481B2 (ja) 1990-11-15 1995-08-09 松谷化学工業株式会社 低カロリー飲食物
DK0514528T3 (da) 1990-12-05 1996-06-10 George E Inglett Opløselig diætfibersammensætning og fremgangsmåde til fremstilling af samme
IT1255488B (it) * 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
IT1298758B1 (it) 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
AU1908500A (en) 1998-11-30 2000-06-19 Hercules Incorporated Controlled release carbohydrate embedded in a crosslinked polysaccharide
FR2840612B1 (fr) 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
GB0221184D0 (en) 2002-09-13 2002-10-23 Cerestar Holding Bv Carbohydrate materials in food and drink compositions
FR2864088B1 (fr) 2003-12-19 2006-04-28 Roquette Freres Polymeres solubles de glucose hautement branches
MY140971A (en) * 2004-07-29 2010-02-12 Brunob Ii Bv Use of a chemically modified starch product
ITMI20042356A1 (it) * 2004-12-10 2005-03-10 Acraf Composizione farmaceutica orodisperdibile e procedimento per prepararla
JP5118316B2 (ja) * 2006-06-26 2013-01-16 花王株式会社 肥満予防・改善剤
JPWO2008081834A1 (ja) * 2006-12-28 2010-04-30 江崎グリコ株式会社 グリコーゲンを含む食品とその用途
EP1943908A1 (en) 2006-12-29 2008-07-16 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Novel slowly digestible storage carbohydrate
AR069960A1 (es) * 2007-12-28 2010-03-03 Acraf Formulacion farmaceutica de liberacion controlada y procedimiento para su preparacion
SG171444A1 (en) * 2009-01-23 2011-07-28 Acraf Controlled release pharmaceutical or food formulation and process for its preparation

Also Published As

Publication number Publication date
JP5639649B2 (ja) 2014-12-10
MX2012001518A (es) 2012-06-08
SG178069A1 (en) 2012-03-29
KR101752335B1 (ko) 2017-06-29
AU2010280835A2 (en) 2012-03-01
EP2461701B1 (en) 2016-04-06
EP2461701A1 (en) 2012-06-13
SI2461701T1 (sl) 2016-07-29
UA106238C2 (ru) 2014-08-11
PL2461701T3 (pl) 2016-09-30
CY1117686T1 (el) 2017-05-17
HRP20160722T1 (hr) 2016-08-12
BR112012002350B1 (pt) 2018-07-03
KR20120052308A (ko) 2012-05-23
EA028124B1 (ru) 2017-10-31
CA2760177C (en) 2019-06-25
WO2011015509A1 (en) 2011-02-10
CA2760177A1 (en) 2011-02-10
US8889654B2 (en) 2014-11-18
CN102469817B (zh) 2013-10-02
DK2461701T3 (en) 2016-07-04
GEP20156287B (en) 2015-05-25
AU2010280835A1 (en) 2012-03-01
IL217462A (en) 2015-06-30
JP2013501021A (ja) 2013-01-10
CN102469817A (zh) 2012-05-23
IL217462A0 (en) 2012-02-29
EA201270238A1 (ru) 2012-07-30
AU2010280835B2 (en) 2015-02-26
AR077343A1 (es) 2011-08-17
HUE027721T2 (en) 2016-10-28
SG10201403719PA (en) 2014-10-30
SMT201600163B (it) 2016-07-01
HK1170387A1 (zh) 2013-03-01
PT2461701E (pt) 2016-06-06
US20120220547A1 (en) 2012-08-30
BR112012002350A2 (pt) 2015-09-01

Similar Documents

Publication Publication Date Title
Parajuli et al. Bone's responses to mechanical loading are impaired in type 1 diabetes
MY210233A (en) Methods and compositions for topical delivery
MX2012003702A (es) Composiciones de carbohidratos que ejercen un mayor impacto sobre la respuesta insulinica que sobre la respuesta glucemica.
MX2010010726A (es) Composicion de estilizado de cabello.
BR112012011294A2 (pt) composição nutritiva para promover o equilíbrio de microbiotas do intestino e a saúde
MX390994B (es) Composicion nutricional que contiene mezcla de oligosacaridos.
CL2013001433A1 (es) Composicion que comprende al menos una n-acetil lactosamina, al menos un oligosacarido sialilado al menos un oligosacarido fucosilado; y su uso en la prevencion de infecciones respiratorias agudas y/o para aliviar los sintomas de dichas infecciones.
CL2013001436A1 (es) Composicion que comprende al menos una n-acetil-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; y su uso para la prevencion y/o tratamiento de las condiciones de la piel y enfermedades de la piel.
AR045569A1 (es) Composiciones alimenticias que tienen un efecto de saciedad aumetado
CL2013001471A1 (es) Composicion que comprende al menos una n-acetil-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado y un hidrolizado que comprende proteinas parcialmente y/o completamente hidrolizadas; y su uso para la prevencion y/o tratamiento de las condiciones de la piel y enfermedades de la piel.
CL2013001470A1 (es) Mezcla de oligosacaridos que comprende al menos una acetil-n-lactosamina, al menos un oligosacarido sialilado y al menos un oligosacarido fucosilado; producto alimenticio que comprende esta mezcla; y su uso para prevenir y reducir el riesgo y/o reducir la severidad y/o reducir la aparicion de alergias a alimentos y los efectos relacionados con la alergia a alimentos sobre la salud.
WO2012074930A3 (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
IN2012DN00570A (es)
MX374694B (es) USO DE 1-CLORO-4-(ß-D-GLUCOPIRANOS-1-IL)-2-[4-((S)-TETRAHIDROFURAN-3-ILOXI)-BENCIL]-BENCENO EN COMBINACIÓN CON INSULINA PARA REDUCIR LA DOSIS DE INSULINA Y PARA MEJORAR EL CONTROL GLUCÉMICO EN PACIENTES CON DIABETES MELLITUS.
SG196810A1 (en) Controlled release pharmaceutical or foodformulation and process for its preparation
MX2013001130A (es) Composiciones de carbohidratos.
WO2012038512A3 (en) Composition comprising sod, lutein and zeaxanthin
BRPI0908541B8 (pt) uso de panax quinquefolius ou uma fração do mesmo na ativação de respostas imunes inatas e adaptativas
MX2009009582A (es) Complejos de hialuronanos, otros componentes de matriz, hormonas y factores de crecimiento para el mantenimiento, expansion y/o diferenciacion de celulas hepaticas.
BR112012019622A2 (pt) muro vegetal com circulação interna de ar
WO2012073170A3 (fr) Composition galénique adaptée à l'administration à un animal non-humain, utilisations de celle-ci et méthodes associées
JP2014501254A5 (es)
AR094150A1 (es) Una composicion de fibras de tomate y metodo para su preparacion
ES2613398T3 (es) Recubrimiento compuesto rico en fibra para productos alimenticios
Koutsos et al. An apple a day keeps the doctor away–inter-relationship between apple consumption, the gut microbiota and cardiometabolic disease risk reduction